English
Segment disclosures
Company overviewBRUKER CORPORATION
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Intersegment Elimination · BSIBMID
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBMIDMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261105 | Open filing evidence |
Intersegment Elimination · Bsi Calid
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BsiCalidMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
Intersegment Elimination · Energy And Supercon Technologies
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 2000000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 8200000 | USD | 20261105 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 3000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 6200000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 3200000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 7700000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1200000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 5700000 | USD | 20261105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2100000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4500000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2400000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 14100000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3800000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 10300000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4000000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 6500000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2500000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 17000000 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 12300000 | USD | 20250303 | Open filing evidence |
Operating Segments · Bruker Bio Spin Group
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerBioSpinGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 233000000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 633300000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 217500000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 400300000 | USD | 20240809 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 198300000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 540600000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 162000000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 342300000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 180300000 | USD | 20230510 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 175700000 | USD | 20231109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 493300000 | USD | 20231109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 159800000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 317600000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 157800000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 691000000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 186500000 | USD | 20221104 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 494400000 | USD | 20221104 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 148500000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 307900000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 159400000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 600000000 | USD | 20210301 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 621400000 | USD | 20210301 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 591100000 | USD | 20210301 | Open filing evidence |
Operating Segments · Bruker Calid Group
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerCalidGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 227900000 | USD | 20240510 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 239300000 | USD | 20231109 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 703200000 | USD | 20231109 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 227200000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 463900000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 236700000 | USD | 20240510 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 207500000 | USD | 20231109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 601000000 | USD | 20231109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 190300000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 393500000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 203200000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 819600000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 194200000 | USD | 20221104 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 579900000 | USD | 20221104 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 193300000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 385700000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 192400000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 653900000 | USD | 20210301 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 623500000 | USD | 20220228 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 547800000 | USD | 20210301 | Open filing evidence |
Operating Segments · Bruker Nano Group
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerNanoGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 287100000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 780000000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 252500000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 492900000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 240400000 | USD | 20240510 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 238700000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 673400000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 225100000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 434700000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 209600000 | USD | 20240510 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 199100000 | USD | 20231109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 559800000 | USD | 20231109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 182200000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 360700000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 178500000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 697500000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 174900000 | USD | 20221104 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 504600000 | USD | 20221104 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 175300000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 329700000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 154400000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 556100000 | USD | 20220228 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 632700000 | USD | 20210301 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 568100000 | USD | 20210301 | Open filing evidence |
Operating Segments · Bsi Biospin
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BsiBiospinMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 798500000 | USD | 20240229 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 180300000 | USD | 20230510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 696700000 | USD | 20240229 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 157800000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 691000000 | USD | 20240229 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 600000000 | USD | 20230301 | Open filing evidence |
Operating Segments · BSIBMID
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBMIDMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 133600000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 395800000 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 130200000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 373300000 | USD | 20261105 | Open filing evidence |
Operating Segments · Bsi Calid
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BsiCalidMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 310300000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 626600000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 316300000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1210200000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 312700000 | USD | 20251105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 878600000 | USD | 20251105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 285800000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 565900000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 280100000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1093500000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 279400000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 772900000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 265600000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 493500000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 227900000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 960400000 | USD | 20260227 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 236700000 | USD | 20230510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 822200000 | USD | 20250303 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 203200000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 819600000 | USD | 20240229 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 653900000 | USD | 20230301 | Open filing evidence |
Operating Segments · Bsi Nano
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BsiNanoMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 941900000 | USD | 20240229 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 209600000 | USD | 20230510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 787000000 | USD | 20240229 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 199100000 | USD | 20221104 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 559800000 | USD | 20221104 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 182200000 | USD | 20220805 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 360700000 | USD | 20220805 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 178500000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 697500000 | USD | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 174900000 | USD | 20221104 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 504600000 | USD | 20221104 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 175300000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 329700000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 154400000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 556100000 | USD | 20230301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 147100000 | USD | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 392700000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 125500000 | USD | 20200807 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 245600000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 120100000 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 632700000 | USD | 20220228 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 169900000 | USD | 20201106 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 461700000 | USD | 20201106 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 151000000 | USD | 20200807 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 291800000 | USD | 20200807 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 140800000 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 568100000 | USD | 20210301 | Open filing evidence |
Operating Segments · Energy And Supercon Technologies
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 82100000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 223100000 | USD | 20261105 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 74200000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 141000000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 66800000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 270900000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 73800000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 199400000 | USD | 20261105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 66300000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 125600000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 59300000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 283000000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 68700000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 210900000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 69100000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 142200000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 73100000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 280700000 | USD | 20260227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 70600000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 205500000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 72700000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 134900000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 62200000 | USD | 20240510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 237100000 | USD | 20250303 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 59300000 | USD | 20231109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 178200000 | USD | 20231109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 59200000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 118900000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 59700000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 223800000 | USD | 20240229 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 57000000 | USD | 20221104 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 166000000 | USD | 20221104 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 56600000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 109000000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 52400000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 189500000 | USD | 20230301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 43800000 | USD | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 134800000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 44800000 | USD | 20200807 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 91000000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 46200000 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 209900000 | USD | 20210301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 52500000 | USD | 20201106 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 152200000 | USD | 20201106 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 51900000 | USD | 20200807 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 99700000 | USD | 20200807 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 47800000 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 194800000 | USD | 20210301 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 50900000 | USD | 2019-11-04 · 21:18:05.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 139200000 | USD | 2019-11-04 · 21:18:05.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 42700000 | USD | 2019-08-09 · 19:26:23.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 88300000 | USD | 2019-08-09 · 19:26:23.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 45600000 | USD | 20190508 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 191200000 | USD | 20200327 | Open filing evidence |
Operating Segments · Scientific Instruments
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 383200000 | USD | 20221104 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1094300000 | USD | 20221104 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 350100000 | USD | 20220805 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 711100000 | USD | 20220805 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 361000000 | USD | 20220506 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1510600000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 380700000 | USD | 20221104 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1074300000 | USD | 20221104 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 341800000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 693600000 | USD | 20220805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 351800000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1253900000 | USD | 20220228 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 323400000 | USD | 20201106 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 842600000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 257800000 | USD | 20200807 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 519200000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 261400000 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1244900000 | USD | 20220228 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 301900000 Restated | USD | 20201106 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 869300000 Restated | USD | 20201106 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 291400000 Restated | USD | 20200807 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 567400000 Restated | USD | 20200807 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 276000000 Restated | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 1138900000 | USD | 20210301 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 417100000 | USD | 2019-11-04 · 21:18:05.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 1206500000 | USD | 2019-11-04 · 21:18:05.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 402400000 | USD | 2019-08-09 · 19:26:23.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 789400000 | USD | 2019-08-09 · 19:26:23.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 387000000 | USD | 20190508 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 1070900000 | USD | 20200327 | Open filing evidence |
Operating Segments · Energy And Supercon Technologies
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 194800000 | USD | 20190301 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 50900000 | USD | 20181109 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 139200000 | USD | 20181109 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 42700000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 88300000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 45600000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 191200000 | USD | 20190301 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 46100000 | USD | 20181109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 140200000 | USD | 20181109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 54000000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 94100000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 40100000 | USD | 20180510 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 130200000 | USD | 20190301 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 35500000 | USD | 20171109 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 91200000 | USD | 20171109 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 28500000 | USD | 20170809 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 55700000 | USD | 20170809 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 27200000 | USD | 20170510 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 133700000 | USD | 20180316 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 32900000 | USD | 20161109 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 91200000 | USD | 20161109 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 30800000 | USD | 20160805 | Open filing evidence |
| 2015-01-01 – 2015-06-30 | 58300000 | USD | 20160805 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 27500000 | USD | 20160506 | Open filing evidence |
| 2014-01-01 – 2014-12-31 | 152900000 | USD | 20170301 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 40000000 | USD | 20151106 | Open filing evidence |
| 2014-01-01 – 2014-09-30 | 116200000 | USD | 20151106 | Open filing evidence |
| 2014-04-01 – 2014-06-30 | 41400000 | USD | 20150807 | Open filing evidence |
| 2014-01-01 – 2014-06-30 | 76200000 | USD | 20150807 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 34800000 | USD | 20150508 | Open filing evidence |
| 2013-01-01 – 2013-12-31 | 147400000 | USD | 20160229 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 32500000 | USD | 20141107 | Open filing evidence |
| 2013-01-01 – 2013-09-30 | 100800000 | USD | 20141107 | Open filing evidence |
| 2012-01-01 – 2012-12-31 | 136200000 | USD | 20150227 | Open filing evidence |
Operating Segments · Scientific Instruments
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-12-31 | 1707000000 | USD | 20190301 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 417100000 | USD | 20181109 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 1206500000 | USD | 20181109 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 402400000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 789400000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 387000000 | USD | 20180510 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 1583900000 | USD | 20190301 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 390600000 | USD | 20181109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 1099500000 | USD | 20181109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 362500000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 708900000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 346400000 | USD | 20180510 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 1492600000 | USD | 20190301 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 361500000 | USD | 20171109 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 1057600000 | USD | 20171109 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 345700000 | USD | 20170809 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 696100000 | USD | 20170809 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 350400000 | USD | 20170510 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 1499200000 | USD | 20180316 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 366600000 | USD | 20161109 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 1060300000 | USD | 20161109 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 366200000 | USD | 20160805 | Open filing evidence |
| 2015-01-01 – 2015-06-30 | 693700000 | USD | 20160805 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 327500000 | USD | 20160506 | Open filing evidence |
| 2014-01-01 – 2014-12-31 | 1674600000 | USD | 20170301 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 383400000 | USD | 20151106 | Open filing evidence |
| 2014-01-01 – 2014-09-30 | 1198800000 | USD | 20151106 | Open filing evidence |
| 2014-04-01 – 2014-06-30 | 421500000 | USD | 20150807 | Open filing evidence |
| 2014-01-01 – 2014-06-30 | 815400000 | USD | 20150807 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 393900000 | USD | 20150508 | Open filing evidence |
| 2013-01-01 – 2013-12-31 | 1709500000 | USD | 20160229 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 410600000 | USD | 20141107 | Open filing evidence |
| 2013-01-01 – 2013-09-30 | 1198500000 | USD | 20141107 | Open filing evidence |
| 2012-01-01 – 2012-12-31 | 1666100000 | USD | 20150227 | Open filing evidence |
Operating Segments · Scientific Instruments · Bruker Bio Spin Group
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;us-gaap:SubsegmentsAxis=brkr:BrukerBioSpinGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-07-01 – 2018-09-30 | 139500000 | USD | 20181109 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 411200000 | USD | 20181109 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 139900000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 271700000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 131800000 | USD | 20180510 | Open filing evidence |
Operating Segments · Scientific Instruments · Bruker Calid Group
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;us-gaap:SubsegmentsAxis=brkr:BrukerCalidGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-07-01 – 2018-09-30 | 134600000 | USD | 20181109 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 393900000 | USD | 20181109 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 128000000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 259300000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 131300000 | USD | 20180510 | Open filing evidence |
Operating Segments · Scientific Instruments · Bruker Nano Group
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;us-gaap:SubsegmentsAxis=brkr:BrukerNanoGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-07-01 – 2018-09-30 | 143000000 | USD | 20181109 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 401400000 | USD | 20181109 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 134500000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 258400000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 123900000 | USD | 20180510 | Open filing evidence |
Bruker Bio Spin Group
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerBioSpinGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 186500000 | USD | 20211105 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 494400000 | USD | 20211105 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 148500000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 307900000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 159400000 | USD | 20210510 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 152100000 | USD | 20211105 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 398100000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 125100000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 246000000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 120900000 | USD | 20210510 | Open filing evidence |
Bruker Bio Spin Group · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerBioSpinGroupMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 182800000 | USD | 20240510 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 180300000 | USD | 20240510 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 600000000 | USD | 20220228 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 621400000 | USD | 20220228 | Open filing evidence |
Bruker Calid Group
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerCalidGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 194200000 | USD | 20211105 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 579900000 | USD | 20211105 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 193300000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 385700000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 192400000 | USD | 20210510 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 171300000 | USD | 20211105 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 444500000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 132700000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 273200000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 140500000 | USD | 20210510 | Open filing evidence |
Bruker Calid Group · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerCalidGroupMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 279400000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 772900000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 265600000 | USD | 20240809 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 493500000 | USD | 20240809 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 239300000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 703200000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 227200000 | USD | 20240809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 463900000 | USD | 20240809 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 653900000 | USD | 20220228 | Open filing evidence |
Bruker Nano Group
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerNanoGroupMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 174900000 | USD | 20211105 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 504600000 | USD | 20211105 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 175300000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 329700000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 154400000 | USD | 20210510 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 147100000 | USD | 20211105 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 392700000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 125500000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 245600000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 120100000 | USD | 20210510 | Open filing evidence |
Bruker Nano Group · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerNanoGroupMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 632700000 | USD | 20220228 | Open filing evidence |
BSIBIOS
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBIOSMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 397200000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1154800000 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 391200000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1117100000 | USD | 20261105 | Open filing evidence |
BSIBIOS · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBIOSMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261105 | Open filing evidence |
BSIBIOS · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBIOSMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 397200000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1154800000 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 391200000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1117100000 | USD | 20261105 | Open filing evidence |
Bsi Biospin
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BsiBiospinMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 195700000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 393200000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 197500000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 878800000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 208700000 | USD | 20251105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 611800000 | USD | 20251105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 195300000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 403100000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 207800000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 905700000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 233000000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 633300000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 217500000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 400300000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 182800000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 798500000 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 696700000 | USD | 20250303 | Open filing evidence |
Bsi Biospin · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BsiBiospinMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
Bsi Biospin · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BsiBiospinMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 195700000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 393200000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 197500000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 878800000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 208700000 | USD | 20251105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 611800000 | USD | 20251105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 195300000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 403100000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 207800000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 905700000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 233000000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 633300000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 217500000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 400300000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 182800000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 798500000 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 696700000 | USD | 20250303 | Open filing evidence |
BSIBMID
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBMIDMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 133600000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 395800000 | USD | 20261105 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 130200000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 373300000 | USD | 20261105 | Open filing evidence |
Bsi Calid
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BsiCalidMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 310300000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 626600000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 316300000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1210200000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 312700000 | USD | 20251105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 878600000 | USD | 20251105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 285800000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 565900000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 280100000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1093500000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 279400000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 772900000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 265600000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 493500000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 227900000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 960400000 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 822200000 | USD | 20250303 | Open filing evidence |
Bsi Nano
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BsiNanoMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 263100000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 770400000 | USD | 20261105 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 261300000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 507300000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 246000000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1084300000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 266500000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 775200000 | USD | 20261105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 252100000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 508700000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 256600000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1098300000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 287100000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 780000000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 252500000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 492900000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 240400000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 941900000 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 787000000 | USD | 20250303 | Open filing evidence |
Bsi Nano · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BsiNanoMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
Bsi Nano · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:BsiNanoMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 263100000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 770400000 | USD | 20261105 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 261300000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 507300000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 246000000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1084300000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 266500000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 775200000 | USD | 20261105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 252100000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 508700000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 256600000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1098300000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 287100000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 780000000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 252500000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 492900000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 240400000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 941900000 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 787000000 | USD | 20250303 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 174900000 | USD | 20211105 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 175300000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 154400000 | USD | 20210510 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 147100000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 125500000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 120100000 | USD | 20210510 | Open filing evidence |
Energy And Supercon Technologies
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 80100000 | USD | 20261105 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 214900000 | USD | 20261105 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 71200000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 134800000 | USD | 20260805 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 63600000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 263200000 | USD | 20260227 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 72600000 | USD | 20261105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 193700000 | USD | 20261105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 64200000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 121100000 | USD | 20260805 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 56900000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 268900000 | USD | 20260227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 64900000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 200600000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 65100000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 135700000 | USD | 20250806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 70600000 | USD | 20250507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 263700000 | USD | 20260227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 224800000 | USD | 20250303 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 57000000 | USD | 20211105 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 166000000 | USD | 20211105 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 56600000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 109000000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 52400000 | USD | 20210510 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 43800000 | USD | 20211105 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 134800000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 44800000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 91000000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 46200000 | USD | 20210510 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 209900000 | USD | 20200327 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 52500000 | USD | 20201106 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 152200000 | USD | 20201106 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 51900000 | USD | 20200807 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 99700000 | USD | 20200807 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 47800000 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 194800000 | USD | 20200327 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 50900000 | USD | 2019-11-04 · 21:18:05.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 139200000 | USD | 2019-11-04 · 21:18:05.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 42700000 | USD | 2019-08-09 · 19:26:23.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 88300000 | USD | 2019-08-09 · 19:26:23.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 45600000 | USD | 20190508 | Open filing evidence |
| 2013-01-01 – 2013-12-31 | 147400000 | USD | 20140227 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 32500000 | USD | 20131108 | Open filing evidence |
| 2013-01-01 – 2013-09-30 | 100800000 | USD | 20131108 | Open filing evidence |
| 2013-04-01 – 2013-06-30 | 37100000 | USD | 20130808 | Open filing evidence |
| 2013-01-01 – 2013-06-30 | 68300000 | USD | 20130808 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 31200000 | USD | 20130509 | Open filing evidence |
| 2012-01-01 – 2012-12-31 | 136200000 | USD | 20140227 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 42400000 | USD | 20131108 | Open filing evidence |
| 2012-01-01 – 2012-09-30 | 98400000 | USD | 20131108 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 26000000 | USD | 20130808 | Open filing evidence |
| 2012-01-01 – 2012-06-30 | 56000000 | USD | 20130808 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 30000000 | USD | 20130509 | Open filing evidence |
| 2011-01-01 – 2011-12-31 | 113400000 | USD | 20140227 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 27700000 | USD | 20121108 | Open filing evidence |
| 2011-01-01 – 2011-09-30 | 79800000 | USD | 20121108 | Open filing evidence |
| 2011-04-01 – 2011-06-30 | 28100000 | USD | 20120809 | Open filing evidence |
| 2011-01-01 – 2011-06-30 | 52100000 | USD | 20120809 | Open filing evidence |
| 2011-01-01 – 2011-03-31 | 24000000 | USD | 20120509 | Open filing evidence |
| 2010-01-01 – 2010-12-31 | 90500000 | USD | 20130228 | Open filing evidence |
| 2010-07-01 – 2010-09-30 | 22400000 | USD | 20111109 | Open filing evidence |
| 2010-01-01 – 2010-09-30 | 61200000 | USD | 20111109 | Open filing evidence |
| 2010-04-01 – 2010-06-30 | 18100000 | USD | 20110809 | Open filing evidence |
| 2010-01-01 – 2010-06-30 | 38800000 | USD | 20110809 | Open filing evidence |
| 2009-01-01 – 2009-12-31 | 59800000 | USD | 20120229 | Open filing evidence |
Energy And Supercon Technologies · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 223800000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 57000000 | USD | 20211105 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 56600000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 52400000 | USD | 20210510 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 189500000 | USD | 20220228 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 43800000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 44800000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 46200000 | USD | 20210510 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 209900000 | USD | 20220228 | Open filing evidence |
Energy And Supercon Technologies · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-04-01 – 2014-06-30 | 41400000 | USD | 20140808 | Open filing evidence |
| 2014-01-01 – 2014-06-30 | 76200000 | USD | 20140808 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 34800000 | USD | 20140509 | Open filing evidence |
| 2013-04-01 – 2013-06-30 | 37100000 | USD | 20140808 | Open filing evidence |
| 2013-01-01 – 2013-06-30 | 68300000 | USD | 20140808 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 31200000 | USD | 20140509 | Open filing evidence |
Scientific Instruments Material Science
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMaterialScienceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 632700000 | USD | 20200327 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 568100000 | USD | 20200327 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 513000000 | USD | 20200327 | Open filing evidence |
Scientific Instruments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-01-01 – 2013-12-31 | 1709500000 | USD | 20140227 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 410600000 | USD | 20131108 | Open filing evidence |
| 2013-01-01 – 2013-09-30 | 1198500000 | USD | 20131108 | Open filing evidence |
| 2013-04-01 – 2013-06-30 | 421600000 | USD | 20130808 | Open filing evidence |
| 2013-01-01 – 2013-06-30 | 787900000 | USD | 20130808 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 366300000 | USD | 20130509 | Open filing evidence |
| 2012-01-01 – 2012-12-31 | 1666100000 | USD | 20140227 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 408900000 | USD | 20131108 | Open filing evidence |
| 2012-01-01 – 2012-09-30 | 1184000000 | USD | 20131108 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 397000000 | USD | 20130808 | Open filing evidence |
| 2012-01-01 – 2012-06-30 | 775100000 | USD | 20130808 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 378100000 | USD | 20130509 | Open filing evidence |
| 2011-01-01 – 2011-12-31 | 1554100000 | USD | 20140227 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 394600000 | USD | 20121108 | Open filing evidence |
| 2011-01-01 – 2011-09-30 | 1108300000 | USD | 20121108 | Open filing evidence |
| 2011-04-01 – 2011-06-30 | 377900000 | USD | 20120809 | Open filing evidence |
| 2011-01-01 – 2011-06-30 | 713700000 | USD | 20120809 | Open filing evidence |
| 2011-01-01 – 2011-03-31 | 335800000 | USD | 20120509 | Open filing evidence |
| 2010-01-01 – 2010-12-31 | 1225100000 | USD | 20130228 | Open filing evidence |
| 2010-07-01 – 2010-09-30 | 290500000 | USD | 20111109 | Open filing evidence |
| 2010-01-01 – 2010-09-30 | 835700000 | USD | 20111109 | Open filing evidence |
| 2010-04-01 – 2010-06-30 | 284900000 | USD | 20110809 | Open filing evidence |
| 2010-01-01 – 2010-06-30 | 545200000 | USD | 20110809 | Open filing evidence |
| 2009-01-01 – 2009-12-31 | 1062700000 | USD | 20120229 | Open filing evidence |
Scientific Instruments · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 380700000 | USD | 20211105 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 341800000 | USD | 20210805 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 351800000 | USD | 20210510 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 323400000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 257800000 | USD | 20210805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 261400000 | USD | 20210510 | Open filing evidence |
Scientific Instruments · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-04-01 – 2014-06-30 | 421500000 | USD | 20140808 | Open filing evidence |
| 2014-01-01 – 2014-06-30 | 815400000 | USD | 20140808 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 393900000 | USD | 20140509 | Open filing evidence |
| 2013-04-01 – 2013-06-30 | 421600000 | USD | 20140808 | Open filing evidence |
| 2013-01-01 – 2013-06-30 | 787900000 | USD | 20140808 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 366300000 | USD | 20140509 | Open filing evidence |